Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Deramiocel (CAP-1002)
BIOLOGICAL
2 trials
Sponsors
Capricor Inc.
Conditions
Duchenne Muscular Dystrophy
Genetic Diseases, Inborn
Genetic Diseases, X-Linked
Muscular Diseases
Muscular Disorders, Atrophic
Muscular Dystrophies
Muscular Dystrophy, Duchenne
Nervous System Diseases
+1 more
Phase 2
Open-label Extension of the HOPE-2 Trial
Active, not recruiting
NCT04428476
Capricor Inc.
Duchenne Muscular Dystrophy
Start: 2020-08-05
End: 2026-05-31
Updated: 2025-11-03
Phase 3
A Study of Deramiocel (CAP-1002) in Ambulatory and Non-Ambulatory Patients With Duchenne Muscular Dystrophy
Active, not recruiting
NCT05126758
Capricor Inc.
Genetic Diseases, Inborn, Genetic Diseases, X-Linked, Muscular Diseases +5
Start: 2022-06-22
End: 2027-03-01
Updated: 2026-08-28
Related Papers
Deramiocel heart-derived cellular therapy in advanced Duchenne muscular dystrophy (HOPE-3): a phase 3, randomised, double-blind, placebo-controlled trial.
2026-07-29